| Tag | Content |
|---|
EnhancerAtlas ID | HS091-10791 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr12:109870820-109872840 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NR2C2 | MA0504.1 | chr12:109871622-109871637 | GGAGGTCAGAGGTGG | + | 6.03 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_00615 | chr12:109870319-109873182 | Adipose_Nuclei |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 109871918 | 109872035 | | chr12 | 109871373 | 109871822 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I109432 | chr12 | 109870506 | 109871204 |
|
Enhancer Sequence | TGACCAGAAG ACCACCAAAT GGTCTCTTCC CTTGACATCA AAGGGTTTTG TGCATTGATC 60
CGTATCCATC TAGAGCCTGG AGACTCGATT CCTAGGGATT TATGGAGATT TGCGAGATTT 120
ATGCTTCATC TACTCGATGT AAATGCAGCT CTTAATTCTT TAGAAGAGCT ATGGTGCTGC 180
CGGTGGGAGG AAATGAAGTT ATAAAGGAAA CTTCCGCACT AAACTGATTT AGCAGATGGG 240
CCTCCTTGCT AGCAAAACAA AGAGGGAACC AGAGGGGGCA CCTAACGTCC GTGTGCCTGG 300
ATTCTTTCAC TGTTCCCATG TACGCATGAC CTGCCAGAGG AGCTACTGGG ACCTAGACAA 360
TGTGAGATCA TCTGTAGCAT CTCAGAAATG GTGTGCTGGA ACTCTTAACT GTAGAGTTGT 420
AGTTATCCAT GAGCAGAGAC TTTCGTACAC ATTGAAAGCT TTCAGGCACA ACTCAAGGGA 480
CATGAATCGG GAAGATCCGA GTCCGTCTTG TGCGTCATTT TGGTCAGGGT TAATGAGGTT 540
GCAGGGAAAG GTGTCTCAGC ATGAAGATCT ATTCCCCGAC AGCAGGGCTT CCCCACTCCA 600
GAGAGCTCTG CCTGTGATCC TGTTCATGGG CTTTCCCTGC TGACTCCTAA CTCCCACTTG 660
TACATGGTCG TCTGGGCCGC CTTGGCCTCT CTCCATCTGT AGACTCCTAT TCTGGGCCTG 720
TTCCAAGGAT CAGTTACTTA GTCAGTCCAG ATCTCCAAGG GGATTCTGCA AGGCTCAGCA 780
CATCCTGAGG GAGGCAGGGC ATGGAGGTCA GAGGTGGGAT CCGTCTGTCC CCTGTTCCAT 840
AAATTGAAAC AGGGACAAGG GAGAGTGGGA TCACCAGGCA CCACCCACTG CTGTCCCCAG 900
TGGCTGCCCT GGGAACTTTC CCTCACCAGG CCTGGGGTCG GGCAGGCAAT GTGAGGTCAG 960
TATTTGTAAC TTCTCTCTGC TGGCTACTGT GATCTTCTTT TTATTTTTTT ATTTTTTGAG 1020
ACAGAGTCTT GCTCTGTCAC CCAGGCTGCA GTGGCATGAT CTCGGCTCAC TGTAACCTCC 1080
GCTTCCTGGG TTCAAGCGAT TCTCCTGCCT TAGCCTCTCG AGTAGCTGGG ATTACAGGTG 1140
CACACTACCA CAATGGGCTA ATTTTTGTAT TTTTAGTAGA GACAGGGTTT CACCGCGTTT 1200
GTCAGGCTGG TCTCAAACTC CTGACCTCAG GTGATTCACC TGCCTCGGCC TCCCAAAGTG 1260
CTGGGATTGC AGGCGTGAGC CACCGCGCCC AGCGTGATCT TCTTTTAAGC TTAGATCCAC 1320
ATTATTTGTC TGGCTGGGCG TGGTGGCTGG TGCCTGTAAT CCCAGCTACT CGGGAGTCTG 1380
AGGCACGAGA ATCATTTGAA CCTGGGAGAT GGGGGTTGCA GTGAGCCGAG ATTGCACCAC 1440
TGCACTCCAG CCTGGGCAAC AAACTGAGAC TCTGTTTCAA AACAAAAACA AAAAACAAAC 1500
AAAAACACCC ATATTCTTTG TCGTCACTCT TTAAAGCCTA GCAACATAAC TTGAAGCAAC 1560
TTCAGGTTAC GTTGGTTTAT TCATTTCCTA GGACTGCGTA ACAGATGATC ACAAAGTGGC 1620
TGATTTAAAA CAAATCTATT CTCTCCTAGT TGTGGAGGCC AGAAATCCAA AAATCAAGAG 1680
TTGGCAGGGC CACATTCCTG CGGGAGCCTC TTTTAGCTCT GGTGGCTCCT GGCATTGCTT 1740
AGCTGTAGCC GTGTCCCTCC AATCTCTGCC TCCGTCCTCA CGTGGGCTCC TCCCTGTGTC 1800
TTTCTGTGTG TATAGAGACA CTCTCAATGG ATTTAGGGCC CACCCTATTC CAGGATGAGC 1860
TCATTTCTAT CCTTACCTCA ATCACATCTG CAAACACTAT TTCCAAATAA GATGGTATTC 1920
TGAGGTTCTG AGTGGAAATG AATTTTTGAA GGGGGCACCG TTCAACCCAC TAGATGGTAA 1980
ACTGACCAAT TAATAACAAA AACATTTCTT TTCACTTCTA 2020
|
